![](https://monteverdelaw.com/wp-content/uploads/case-logo/syneos-health-inc.png)
Syneos Health, Inc. (NASDAQ: SYNH), relating to its proposed sale to Elliott Investment Management, Patient Square Capital, and Veritas Capital. Under the terms of the agreement, SYNH shareholders are expected to receive $43.00 in cash per share they own.